Nanostructured Coatings for Controlling Bacterial Biofilms and Antibiotic Resistance

Total Page:16

File Type:pdf, Size:1020Kb

Nanostructured Coatings for Controlling Bacterial Biofilms and Antibiotic Resistance Nanostructured coatings for controlling bacterial biofilms and antibiotic resistance Kristina Dimitrova Ivanova A thesis submitted in fulfilment of the requirements for degree of Doctor of Philosophy at the Universitat Politècnica de Catalunya Supervised by Dr. Tzanko Tzanov Group of Molecular and Industrial Biotechnology (GBMI) Department of Chemical Engineering Universitat Politècnica de Catalunya Terrassa (Barcelona) 2017 The work carried out during the thesis was financially supported by: Novel approaches for prevention of biofilms formed on medical indwelling devices, e.g. catheters FP7-HEALTH-2011-278402 Group of Molecular and Industrial Biotechnology Terrassa “My strength is my family” To the people I love the most, Stanimir and my parents Abstract The accelerated emergence of drug resistant bacteria is one of the most serious problems in healthcare and the difficulties in finding new antibiotics make it even more challenging. To overcome the action of conventional antibiotics bacteria develop effective resistance mechanisms including the formation of biofilms. Biofilms are bacterial communities of cells embedded in a self-produced polymeric matrix commonly found on medical devices such as indwelling catheters. When pathogens adopt this mode of growth on the surface, they effectively circumvent host immune defences and antibiotic therapy, causing severe and life threatening device-related infections. To reduce the incidence of biofilm-associated infections different strategies, such as often replacement of the device, utilisation of novel materials for its construction and/or design of functional coatings have been suggested. Besides the variable efficiency, they commonly involve the use of large quantities of antibacterials leading to side effects, hypersensitivity, inflammatory responses or emergence of resistance. Thus, new paradigms are urgently needed for more efficient and specific approaches to prevent and treat biofilm infections. This thesis focuses on the development of advanced nanoscale materials and coatings for controlling clinically relevant bacterial biofilms and the emergence of drug resistance. To this end, acylase and amylase enzymes degrading essential for the biofilm growth components, were innovatively combined into hybrid nanocoatings to impart antibiofilm functionalities onto indwelling medical devices. Alternatively, ultrasound-assisted nanotransformation of antimicrobials was used as a tool for enhancing their antibacterial efficacy and overcoming the intrinsic drug resistant mechanisms in Gram-negative bacteria. These strategies offer new perspectives for prevention and treatment of biofilm infections, limiting the selection and spread of antibiotic resistance. The first part of the thesis describes the building of enzyme multilayer coatings able to interfere with bacterial quorum sensing (QS) and prevent biofilm establishment on silicone urinary catheters. This was achieved by alternate deposition of negatively charged acylase and oppositely charged polyethylenimine in a Layer-by-Layer (LbL) fashion. The acylase-coated catheters degraded the bacterial signalling molecules and inhibited the QS process of Gram-negative bacteria. These coatings also significantly reduced the biofilm growth on urinary catheters under conditions mimicking the real situation in catheterised patients, without affecting the human cells viability. i Acylase was further combined with the matrix degrading α-amylase enzyme into hybrid multilayer coatings able to interfere simultaneously with bacterial QS signals and biofilm integrity. The LbL assembly of both enzymes into hybrid nanocoatings resulted in stronger biofilm inhibition as a function of acylase or amylase location in the multi- layer coating. Hybrid nanocoatings with the QS inhibiting acylase as outermost layer reduced the occurrence of single and multi-species biofilms on silicone catheters in vitro and in an in vivo animal model. The thesis also reports on the efficacy of nanomaterials for prevention and eradication of antibiotic resistant biofilms. Multilayer assemblies that contain in their structure and release on demand antibacterial polycationic nanospheres (NSs) were engineered on silicone surfaces. A polycationic aminocellulose (AC) conjugate was first transformed into NSs with enhanced bactericidal activity and then combined with hyaluronic acid to build bacteria-responsive layers on silicone material. When challenged with bacteria these multilayers disassembled gradually inhibiting both planktonic and biofilm modes of bacterial growth. The same AC NSs were also covalently immobilised on silicone material using epoxy-amine conjugation chemistry. The intact NSs on the silicone material were able to inhibit bacterial colonisation and biofilm growth, suggesting the potential of epoxy- amine curing reaction for generation of stable non-leaching coatings on silicone-based medical devices. Finally, ultrasound-assisted nanotransformation of clinically relevant antibiotic penicillin G was used as a strategy to boost its activity towards Gram-negative bacteria and their biofilms. The efficient penetration of the spheres within a Langmuir monolayer sustained the theory that NSs are able to cross the membrane and reach the periplasmic space in Gram-negative bacteria where they may exert their bactericidal activity “unrecognised” as a threat by bacteria. In such conditions it is very likely that the selective pressure is reduced and bacteria do not feel the need to defend, expressing resistant phenotypes. Keywords: enzymes, Layer-by-Layer coatings, sonochemistry, nanospheres, silicone, urinary catheters, quorum quenching, antibacterial activity, biofilm prevention, antibiotic resistance ii Table of Contents Abstract ........................................................................................... i Table of Contents ........................................................................... iii Abbreviation list .............................................................................. vi 1 Introduction .............................................................................. 1 2 State-Of-The Art ...................................................................... 4 2.1 Bacterial Biofilms Formation ........................................................................... 5 2.2 Quorum Sensing in Bacterial Virulence and Biofilm Growth ............................ 7 2.2.1 Quorum Sensing in Gram-negative Bacteria ............................................ 7 2.2.2 Quorum Sensing in Gram-positive Bacteria ........................................... 10 2.3 Antibiotic Resistance of Biofilms ................................................................... 12 2.4 Biofilms in Device-Related Infections ............................................................ 12 2.5 Current Strategies for Controlling Bacterial Biofilms ...................................... 17 2.6 Layer by Layer assembly: A versatile tool for engineering bacteria resistant materials ................................................................................................................. 18 2.7 Quorum Sensing Inhibitors in Next Generation Antibiofilm Coatings ............. 25 2.8 Enzymes in Biofilms Prevention .................................................................... 28 2.8.1 Quorum Quenching Enzymes ................................................................ 28 2.8.2 Matrix-degrading Enzymes .................................................................... 29 2.8.3 Enzymes Targeting Bacterial Cells ........................................................ 31 2.8.4 Enzymes Producing Biocides ................................................................ 33 2.9 Nanomaterials for Controlling Bacterial Biofilms ........................................... 34 2.9.1 Sonochemistry for Synthesis of Nanoparticles ....................................... 35 2.9.2 Nanoparticles Interaction with Bacteria and Biofilms .............................. 36 2.9.3 Metal and Metal Oxide Nanoparticles .................................................... 38 2.9.4 Nanoantibiotics ...................................................................................... 40 3 Objectives of the Thesis ......................................................... 42 4 Materials and Methods ........................................................... 45 4.1 Materials and Reagents ................................................................................ 46 4.2 Bacterial and Human cells ............................................................................ 46 4.3 Experimental Methods .................................................................................. 47 4.3.1 Enzymatic Degradation of Biofilm Components ..................................... 47 4.3.2 Enzyme Multilayer Coatings for Prevention of Bacterial Biofilm Formation on Silicone Foley Catheters ................................................................................. 48 iii 4.3.3 Nanomaterials for Controlling Planktonic Bacterial Growth and Biofilm Occurrence: Polycationic Aminocellulose Nanospheres ....................................... 57 4.3.4 Covalent Grafting Of Aminocellulose Nanospheres onto Silicone Material for Escherichia Coli Biofilm Prevention ................................................................ 60 4.3.5 Nano-sized Penicillin G for Overcoming Gram-Negative Bacterial Resistance ..........................................................................................................
Recommended publications
  • Enantioselektive Biotransformationen Zur Synthese Von Molekülen Mit
    Untersuchung zur Produktion und gerichteten Immobilisierung einer Alginat Lyase aus Sphingomonas sp. A1 Dissertation zur Erlangung des akademischen Grades doctor rerum naturalium (Dr. rer. nat.) vorgelegt der Naturwissenschaftlichen Fakultät I Biowissenschaften der Martin-Luther-Universität Halle-Wittenberg von Herrn Dipl.-Biol. Christian Beyerodt geboren am 15.12.1982 in Halle an der Saale Halle (Saale) 2015 Gutachter/in: 1. Prof. Dr. Markus Pietzsch 2. Prof. Dr. Reinhard Neubert 3. Prof. Dr. Christoph Syldatk Tag der öffentlichen Verteidigung: 30.03.2016 2 Selbstständigkeitserklärung Hiermit erkläre ich, Christian Beyerodt, dass ich die vorliegende Arbeit - mit Ausnahme der aufgeführten Personen, Unterlagen bzw. Literaturstellen - selbstständig und ohne fremde Hilfe angefertigt habe, _________________ Halle, Datum 3 Danksagung Die vorliegende Dissertation entstand während meiner Tätigkeit als wissenschaftlicher Mitar- beiter in der Arbeitsgruppe „Aufarbeitung biotechnischer Produkte“ des Institutes für Phar- mazie an der Martin-Luther-Universität Halle-Wittenberg. Viele Menschen haben mich wäh- rend dieser Zeit unterstützt und dazu beigetragen, dass ich diese Zeit der Promotion als ei- nen positiven Lebensabschnitt in Erinnerung behalten werde. Diesen Personen möchte ich im Folgenden danken. Zuerst möchte ich mich bei Prof. Dr. Markus Pietzsch für das entgegengebrachte Vertrauen, mir das Thema zu überlassen, bedanken. Auch danke ich für die vielen konstruktiven Dis- kussionen, Kritiken und Hilfestellungen, welche diese Arbeit erst ermöglichten. Weiterhin danke ich der Firma Lanxess, im speziellen Frau Dr. Hermsdorf und Herrn Dr. Schellenberg. Das interdisziplinäre Projekt wurde die Grundlage für meine Forschungen. Ich danke natürlich auch der gesamten Arbeitsgruppe „AG-Pietzsch“ für die schöne Zeit und die zahlreichen Aktivitäten neben der Arbeit. Die Sommerfeste waren immer ein riesen Spaß.
    [Show full text]
  • Analysis of Carbohydrates and Glycoconjugates by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry: an Update for 2011–2012
    ANALYSIS OF CARBOHYDRATES AND GLYCOCONJUGATES BY MATRIX-ASSISTED LASER DESORPTION/IONIZATION MASS SPECTROMETRY: AN UPDATE FOR 2011–2012 David J. Harvey* Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford, Oxford OX1 3QU, UK Received 19 June 2014; accepted 15 January 2015 Published online in Wiley Online Library (wileyonlinelibrary.com). DOI 10.1002/mas.21471 This review is the seventh update of the original article published text. As the review is designed to complement the earlier work, in 1999 on the application of MALDI mass spectrometry to the structural formulae, etc. that were presented earlier are not analysis of carbohydrates and glycoconjugates and brings repeated. However, a citation to the structure in the earlier work coverage of the literature to the end of 2012. General aspects is indicated by its number with a prefix (i.e., 1/x refers to such as theory of the MALDI process, matrices, derivatization, structure x in the first review and 2/x to structure x the second). MALDI imaging, and fragmentation are covered in the first part Books, general reviews, and review-type articles directly of the review and applications to various structural types concerned with, or including, MALDI analysis of carbohydrates constitute the remainder. The main groups of compound are and glycoconjugates to have been published during the review oligo- and poly-saccharides, glycoproteins, glycolipids, glyco- period are listed in Table 1. Reviews relating to more specific sides, and biopharmaceuticals. Much of this material is presented aspects of MALDI analysis are listed in the appropriate sections. in tabular form. Also discussed are medical and industrial applications of the technique, studies of enzyme reactions, and II.
    [Show full text]
  • The Nanotoxicology of a Newly Developed Zero-Valent Iron
    The nanotoxicology of a newly developed zero-valent iron nanomaterial for groundwater remediation and its remediation efficiency assessment combined with in vitro bioassays for detection of dioxin-like environmental pollutants Von der Fakultät für Mathematik, Informatik und Naturwissenschaften der RWTH Aachen University zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften genehmigte Dissertation vorgelegt von Diplom-Biologe Andreas Herbert Schiwy aus Tarnowitz (Polen) Berichter: Universitätsprofessor Dr. rer. nat. Henner Hollert Universitätsprofessor Dr. rer. nat. Andreas Schäffer Tag der mündlichen Prüfung 28. Juli 2016 Diese Dissertation ist auf den Internetseiten der Universitätsbibliothek online verfügbar. To my wife and my children Summary Summary The assessment of chemicals and new compounds is an important task of ecotoxicology. In this thesis a newly developed zero-valent iron material for nanoremediation of groundwater contaminations was investigated and in vitro bioassays for high throughput screening were developed. These two elements of the thesis were combined to assess the remediation efficiency of the nanomaterial on the groundwater contaminant acridine. The developed in vitro bioassays were evaluated for quantification of the remediation efficiency. Within the NAPASAN project developed iron based nanomaterial showed in a model field application its nanoremediation capabilities to reduce organic contaminants in a cost effective way. The ecotoxicological evaluation of the nanomaterial in its reduced and oxidized form was conducted with various ecotoxicological test systems. The effects of the reduced nanomaterial with field site resident dechlorinating microorganisms like Dehalococcoides sp., Desulfitobacterium sp., Desulfomonile tiedjei, Dehalobacter sp., Desulfuromonas sp. have been investigated in batch und column experiments. A short-term toxicity of the reduced nanomaterial was shown.
    [Show full text]
  • Glycoside Hydrolase Dish from Desulfovibrio Vulgaris Degrades The
    Glycoside Hydrolase DisH from Desulfovibrio vulgaris Degrades the N-Acetylgalactosamine Component of Diverse Biofilms Lei Zhu1, Venkata G. Poosarla1, Sooyeon Song1, Thammajun L. Wood1, Daniel S. Miller3, Bei Yin3, and Thomas K. Wood1, 2* 1Department of Chemical Engineering and 2Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, 16802 3Dow Chemical Company, Collegeville, PA, 19426 *To whom correspondence should be addressed: [email protected] Running title: D. vulgaris DisH disperses its biofilm This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process which may lead to differences between this version and the Version of Record. Please cite this article as an ‘Accepted Article’, doi: 10.1111/1462-2920.14064 This article is protected by copyright. All rights reserved. SIGNIFICANCE The global costs of corrosion are more than $2.5 trillion every year (3.4% of the global gross domestic product), and a large part of corrosion (30%) is microbiologically influenced corrosion (MIC), which affects oil production, drinking water systems, and pipelines. MIC is commonly caused by sulfate- reducing bacteria (SRB) biofilms, and Desulfovibrio vulgaris is the model organism. The biofilm matrix of D. vulgaris consists of proteins and polysaccharides of mannose, fucose, and N-acetylgalactosamine (GalNAc). However, little is known about how to control its biofilm formation. Since bacteria must degrade their biofilm to disperse, in this work, we identified and then studied predicted secreted glycoside hydrolases from D. vulgaris. We show here that DisH (DVU2239, dispersal hexosaminidase), a previously uncharacterized protein, is an N-acetyl-β-D-hexosaminidase that disperses the D.
    [Show full text]
  • Nanotechnology and Health Risks
    NANOTECHNOLOGY AND HEALTH RISKS Nanotechnology is being hailed as the “next industrial revolution”. Nanomaterials are now found in hundreds of products, from cosmetics to clothing to food products. Inevitably, these nanomaterials will enter our bodies as we handle nanomaterials in the workplace, eat nano-foods, wear nano-clothes and nano- cosmetics, use nano-appliances and dispose of nano waste into the environment. Early scientific studies demonstrate the potential for materials that are benign in bulk form to become harmful at the nanoscale. There is an urgent need for regulations to protect workers, the public and the environment from nanotoxicity’s risks, for greater understanding of the short and long-term implications of nanotechnology for people’s health and the environment, for consideration of nanotechnology’s broader social implications and for public involvement in decision making regarding nanotechnology’s introduction. What is “nanotechnology” and how is it used? “Nanotechnology” refers to the design, production and application of structures, devices or systems at the incredibly small scale of atoms and molecules – the “nanoscale”. “Nanoscience” is the study of phenomena and the manipulation of materials at this scale, generally understood to be 100 nanometres (nm) or less1. To put 100nm in context, a single strand of DNA measures 2.5nm across, red blood cells measure about 7,000nm and a human hair is 80,000nm wide. Most observers do not make a distinction between nanotechnology and nanoscience and use the term nanotechnology to encompass production and use of nanoscale materials (“nanomaterials”). Nanomaterials are “first generation” products of nanotechnology and FACT SHEET have already entered wide-scale commercial use.
    [Show full text]
  • Nanotoxicology: Toxicological and Biological Activities of Nanomaterials - Yuliang Zhao, Bing Wang, Weiyue Feng, Chunli Bai
    NANOSCIENCE AND NANOTECHNOLOGIES - Nanotoxicology: Toxicological and Biological Activities of Nanomaterials - Yuliang Zhao, Bing Wang, Weiyue Feng, Chunli Bai NANOTOXICOLOGY: TOXICOLOGICAL AND BIOLOGICAL ACTIVITIES OF NANOMATERIALS Yuliang Zhao, CAS Key Lab for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, The Chinese Academy of Sciences, Beijing 100049, & National Center for Nanoscience and Technology of China, Beijing 100190, China Bing Wang, CAS Key Lab for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, The Chinese Academy of Sciences, Beijing 100049 Weiyue Feng, CAS Key Lab for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, The Chinese Academy of Sciences, Beijing 100049 Chunli Bai National Center for Nanoscience and Technology of China, Beijing 100190, China The Chinese Academy of Sciences, Beijing 100864, China Keywords: Nanotoxicology, Nanosafety, Nanomaterials, Nanoparticles, Contents 1. Introduction 2. Target organ toxicity of nanoparticles 2.1. Respiratory System 2.1.1. Deposition of Nanoparticles in the Respiratory Tract 2.1.2. Clearance of Nanoparticles in the Respiratory Tract 2.1.3. Nanotoxic Response of Respiratory System 2.2. Gastrointestinal System 2.3. Cardiovascular System 2.4. Central Nervous System 2.5. Skin 3. Absorption,UNESCO distribution, metabolism and excretion– EOLSS of nanoparticles (ADME) 3.1. ADME of Nanoparticle Following Inhalation Exposure 3.1.1. Absorption and Retention of Nanoparticles Following Respiratory Tract Exposure 3.1.2. Translocation and Distribution of Nanoparticles Following Respiratory Tract Exposure SAMPLE CHAPTERS 3.1.3. Metabolism and Excretion of Nanoparticles in the Lung 3.2. ADME of Nanoparticle via Gastrointestinal Tract 3.3. ADME of Nanoparticles via Skin 4.
    [Show full text]
  • The Efficacy of Lyticase and Β-Glucosidase Enzymes on Biofilm
    Banar et al. BMC Microbiology (2019) 19:291 https://doi.org/10.1186/s12866-019-1662-9 RESEARCH ARTICLE Open Access The efficacy of lyticase and β-glucosidase enzymes on biofilm degradation of Pseudomonas aeruginosa strains with different gene profiles Maryam Banar1, Mohammad Emaneini1, Reza Beigverdi1, Rima Fanaei Pirlar1, Narges Node Farahani1, Willem B. van Leeuwen2 and Fereshteh Jabalameli1* Abstract Background: Pseudomonas aeruginosa is a nosocomial pathogen that causes severe infections in immunocompromised patients. Biofilm plays a significant role in the resistance of this bacterium and complicates the treatment of its infections. In this study, the effect of lyticase and β-glucosidase enzymes on the degradation of biofilms of P. aeruginosa strains isolated from cystic fibrosis and burn wound infections were assessed. Moreover, the decrease of ceftazidime minimum biofilm eliminating concentrations (MBEC) after enzymatic treatment was evaluated. Results: This study demonstrated the effectiveness of both enzymes in degrading the biofilms of P. aeruginosa.In contrast to the lyticase enzyme, β-glucosidase reduced the ceftazidime MBECs significantly (P < 0.05). Both enzymes had no cytotoxic effect on the A-549 human lung carcinoma epithelial cell lines and A-431 human epidermoid carcinoma cell lines. Conclusion: Considering the characteristics of the β-glucosidase enzyme, which includes the notable degradation of P. aeruginosa biofilms and a significant decrease in the ceftazidime MBECs and non-toxicity for eukaryotic cells, this enzyme can be a promising therapeutic candidate for degradation of biofilms in burn wound patients, but further studies are needed. Keywords: Pseudomonas aeruginosa, β-Glucosidase, Lyticase, Biofilm Background patients and associated with chronic infections and antibiotic Pseudomonas aeruginosa is a nosocomial pathogen that resistance [4, 8].
    [Show full text]
  • The Action of Selected Isothiocyanates on Bacterial Biofilm Prevention and Control
    This article was published in International Biodeterioration & Biodegradation 86, 25-33, 2014 http://dx.doi.org/10.1016/j.ibiod.2013.01.015 The action of selected isothiocyanates on bacterial biofilm prevention and control Anabela Borges a,b, Lúcia C. Simões a,c, Maria J. Saavedra b, Manuel Simões a,* a LEPAE, Department of Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, s/n, 4200-465 Porto, Portugal b CECAV e Veterinary and Animal Science Research Center, Veterinary Science Department, University of Trás-os-Montes e Alto Douro, Apartado 1013, 5001- 801 Vila Real, Portugal c IBB e Institute for Biotechnology and Bioengineering, Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal Abstract The activity of two selected isothiocyanates (ITCs), allylisothiocyanate (AITC) and 2-phenylethy- lisothiocyanate (PEITC) was evaluated on the prevention and control of biofilms formed by Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Listeria monocytogenes. In addition, the effect of ITCs was also tested on planktonic cell susceptibility, bacterial motility and adhesion. Biofilm prevention and control were tested using a microtiter plate assay and the effect of ITCs was assessed on biofilm mass and metabolic activity. The minimum bactericidal concentration for E. coli and P. aeruginosa was 1000 g mL-1 (AITC) and > 1000 g mL-1 (PEITC), for S. aureus and L. monocytogenes was > 1000 g mL-1 (for both ITCs). AITC caused total inhibition of swimming (P. aeruginosa) and swarming (E. coli) motilities. PEITC caused total inhibition of swimming (E. coli, P. aeruginosa and L. monocytogenes) and swarming (E.
    [Show full text]
  • Biofilms As Promoters of Bacterial Antibiotic Resistance and Tolerance
    antibiotics Review Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance Cristina Uruén 1,† , Gema Chopo-Escuin 1,†, Jan Tommassen 2 , Raúl C. Mainar-Jaime 1 and Jesús Arenas 1,* 1 Unit of Microbiology and Immunology, Faculty of Veterinary, University of Zaragoza, Miguel Servet, 177, 50017 Zaragoza, Spain; [email protected] (C.U.); [email protected] (G.C.-E.); [email protected] (R.C.M.-J.) 2 Department of Molecular Microbiology, Institute of Biomembranes, Utrecht University, 3584 CH Utrecht, The Netherlands; [email protected] * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: Multidrug resistant bacteria are a global threat for human and animal health. However, they are only part of the problem of antibiotic failure. Another bacterial strategy that contributes to their capacity to withstand antimicrobials is the formation of biofilms. Biofilms are associations of microorganisms embedded a self-produced extracellular matrix. They create particular environments that confer bacterial tolerance and resistance to antibiotics by different mechanisms that depend upon factors such as biofilm composition, architecture, the stage of biofilm development, and growth condi- tions. The biofilm structure hinders the penetration of antibiotics and may prevent the accumulation of bactericidal concentrations throughout the entire biofilm. In addition, gradients of dispersion of nutrients and oxygen within the biofilm generate different metabolic states of individual cells and favor the development of antibiotic tolerance and bacterial persistence. Furthermore, antimicrobial resistance may develop within biofilms through a variety of mechanisms. The expression of efflux pumps may be induced in various parts of the biofilm and the mutation frequency is induced, while the presence of extracellular DNA and the close contact between cells favor horizontal gene transfer.
    [Show full text]
  • ROLE of in VIVO-INDUCED GENES ILVI and HFQ in the SURVIVAL and VIRULENCE of ACTINOBACILLUS PLEUROPNEUMONIAE By
    ROLE OF IN VIVO-INDUCED GENES ILVI AND HFQ IN THE SURVIVAL AND VIRULENCE OF ACTINOBACILLUS PLEUROPNEUMONIAE By Sargurunathan Subashchandrabose A DISSERTATION Submitted to Michigan State University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Comparative Medicine and Integrative Biology 2011 ABSTRACT ROLE OF IN VIVO-INDUCED GENES ILVI AND HFQ IN THE SURVIVAL AND VIRULENCE OF ACTINOBACILLUS PLEUROPNEUMONIAE By Sargurunathan Subashchandrabose Actinobacillus pleuropneumoniae is the etiological agent of porcine pleuropneumonia, a contagious and often fatal disease of pigs. Infection with this bacterium leads to the development of a fulminant pleuropneumonia resulting in severe damage to the lungs. A. pleuropneumoniae genes that are up-regulated during the infection of pig lungs were previously identified in our laboratory and designated as in vivo-induced genes. The role of two such in vivo-induced genes, ilvI and hfq, in the pathobiology of A. pleuropneumoniae is the subject of this dissertation. The gene ilvI encodes an enzyme involved in the biosynthesis of branched-chain amino acids (BCAAs). The leucine-responsive regulatory protein (Lrp) is a transcriptional regulator of the ilvIH operon. BCAA biosynthetic genes are associated with virulence in pathogens infecting the respiratory tract and blood stream. Also, twenty five percent of the A. pleuropneumoniae in vivo-induced genes were up-regulated under BCAA limitation, suggesting that these BCAAs may be found at limiting concentrations in certain sites of the mammalian body such as the respiratory tract. The concentration of amino acids in the porcine pulmonary epithelial lining fluid was determined and BCAAs were found at limiting concentration in the respiratory tract.
    [Show full text]
  • Enzyme Dynamics of Biofilm-Breaking Dispersin B
    Enzyme Dynamics of Biofilm-Breaking Dispersin B Kim, Edward (School: Kalaheo High School) Biofilm-based infections pose two major problems: extreme resistance to antibiotics and many other conventional antimicrobial agents and extreme capacity for evading the host defenses. Dispersin B is a glycoside hydrolase that hydrolyzes the linear polymers in poly-β-1,6-N-acetylglucosamine, considered the main component of the biofilm. Thus, understanding the enzyme dynamics of biofilm-breaking Dispersin B and the nature of the substrate transition state would be important to develop effective antibiotic strategies. To obtain thermodynamic activation parameters, assays of Dispersin B and a biofilm from Staphylococcus aureus were conducted. Dispersin B successfully disturbed biofilm formation due to its cleaving abilities. Additionally, various concentrations of glucose were added to bacteria media, and addition of glucose was found to improve the biofilm formation. Using the optimal concentration of 8 mg/L glucose, independent temperature-controlled assays were performed with varying degrees of substrate concentration to determine the rate constant, which was input in the Arrhenius and Eyring equations. From the resulting thermodynamic values, the Gibbs free energy of activation was determined to be 62.9 kJ/mol at 37 degrees Celsius. Molecular dynamics simulations were performed to predict the transition state structure. After chemically drawn and optimized using the program Avogadro, the substrate analog (4-Nitrophenyl N-acetyl-β-D-glucosaminide) and the potential transition state structure were docked in the active site of Dispersin B. After 1ns molecular dynamics simulations, the potential transition state was observed. This computational method could yield better models of transition-state inhibitors for drug design.
    [Show full text]
  • Nanotoxicology Program Jenny R
    Nanotoxicology Program Jenny R. Roberts, Ph.D. HELD/ACIB NTRC Toxicology and Internal Dose Critical Area Coordinator National Institute for Occupational Safety and Health Morgantown, WV Definitions • Nanoparticle: – A particle having one dimension less than 100 nm. Carbon Nanotube (1 nanometer) x 100,000 = Strand of Hair (100 microns) • Engineered Nanoparticle: – Created for a purpose with tightly controlled size, shape, surface features and chemistry. • Incidental Nanoparticle: – Created as an inadvertent side product of a process. Growth of Nanotoxicology as a Field of Study Scopus: Nanoparticles and Toxicity 3000 2500 1990's Emergence of Nanotech Companies 2000 2004 1st NTRC Science Meeting 1500 1980's Discovery of Early 1990's 2000 Nanocrystals Carbon 1000 National and Fullerenes Nanotubes Publication Number Publication Nanotechnology Innitiative 500 0 1980 1985 1990 1995 2000 2005 2010 2015 Year Timeline and Images: www.nano.gov Nanotechnology Research Center (NTRC) NTRC: 10 Critical Areas NIOSH Program Toxicology & Internal Dose Measurement Recommendations & Guidance Methods Informatics & Exposure Applications Assessment NTRC Global Epidemiology & Collaborations Surveillance Risk Fire & Explosion Assessment Safety Controls & PPE 2016 Nanotoxicology Projects: 11 HELD, 13 NTRC > 40 Extramural Collaborations – Academia, Government, Industrial • Strategic Plan Goals Pertaining to Toxicology 1. Increase understanding of new hazards and related health risks to nanomaterial workers. Conduct research to contribute to the understanding of the toxicology and internal dose of emerging ENMs. Determine whether nanomaterial toxicity can be categorized on the basis of physicochemical properties and mode of action. 2. Expand understanding of the initial hazard findings of engineered nanomaterials. Determine whether human biomarkers of nanomaterial exposure and/or response can be identified.
    [Show full text]